![]() |
首页 > 美迪医讯 > Research Report on Chinese diabetes Market |
Research Report on Chinese diabetes Market 【 2008-08-04 发布 】 美迪医讯
Research Report on Chinese diabetes MarketPublisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published: July 2006
Format: Hardcopy and Adobe PDF
Price: US$2,400
Contact: Mr.Humphrey
Tel.: 86-10-58110925 Fax: 86-10-58110918
E-mail: hhuang@medicexchange.com
Table of contents
Abstract
Foreword
1 Epidemiology of diabetes in China
1.1 Trend of Epidemiology and current status
1.2 Examples of Epidemiology investigation
1.3 Etiological factors in China
2 Categories and action mechanisms of antidiabetic drugs
2.1 Categories
2.2 Action mechanisms
2.3 Marketed breeds in China
2.4 Breeds adopted in catalogue of Drugs for Basic National Medical Insurance
3 Market analysis of antidiabetic drugs
3.1 Market scale and category share
3.2 Leading breeds last year last year
3.3 Leading enterprises last year
3.4 Market analysis of sulfonylurea class
3.4.1 Glipizide
3.4.2 Gliquidone
3.4.3 Gliclazide
3.4.4 Glimepiride
3.4.5 Glibenclamide
3.4.6 Tolbutamide
3.5 Market analysis of biguanides class
3.5.1 sales value
3.5.2 Breakdown of Metformin
3.6 α-glucosidase inhibitor
3.6.1 Acarbose
3.6.2 Voglibose
3.7 Insulin sensitizer
3.8 Insulin secretagogues
3.8.1 Repaglinide
3.8.2 Nateglinide
3.9 Insulin class
3.10 Prepared Chinese Medicine
3.11 General trend of oral antidiabetic drugs
4 Research and development in China
4.1 List of Domestic marketd products and import procucts
4.2 Status of application and approval
本文关键字:
《美迪医讯》欢迎您参与新闻投稿,业务咨询: 美迪医疗网业务咨询《上海医疗器械批发》产品推荐
|
合作支持:中华医学会 | 中华医院管理学会 | 国家食品药品监督管理家用护理器械商城 | 国药励展展览有限责任公 | 医学装备协会 |
刊登广告 | 友情链接 | 广告代理商加盟 | 关于美迪 | 法律声明 | 隐私保护 | 网站地图 |
把美迪网放进收藏夹 把美迪医疗网介绍给我的朋友 给美迪医疗网留言
美迪医疗网广告业务联系:021-51601230 产品咨询业务联系:021-51601230 传真:021-56532303 ![]() 互联网药品信息服务许可证:(沪)-经营性-2009-0003 中华人民共和国电信与信息服务业务经营许可证:(沪)B2-20090029 ![]() ![]() ![]() 公安备案号 31010602000199 医疗器械经营许可证: 沪静药监械经营许20210003号 第二类医疗器械经营备案凭证: 沪静药监械经营备20220042号 营业执照:统一社会信用代码91310108676284138X互联网药品信息服务资格书:(沪)-非经营性-2023-0081 |